BioHybrid Solutions

BioHybrid Solutions in Sharpsburg believes it’s on the verge of a breakthrough in the fight against cancer. The company is deploying its advanced chemistry platform to create injectable drugs that target only cancer cells – sparing healthy cells, and thus creating fewer side effects. “This could be a game changer,” says company President and CEO Laura E. Benjamin To help advance the company’s important work, the Foundation in 2023 invested $250,000 in BioHybrid Solutions, through the Foundation’s Social-Impact Investment program, where the Foundation invests in for-profit companies with a social mission that aligns with the Foundation’s philanthropy. Helping scientists and physicians to fight diseases has been one of the Foundation’s goals since its founding. You can read about the important work underway at BioHybrid Solutions in the Foundation’s 2023 Annual Report, now available on the Foundation website. #philanthropy #healthandwellbeing #cancer #socialimpactinvesting

Nice report coming out later today from Stifel Institutional “Bullish on Biotech” despite continued negative sentiment. They cite 7 fundamental positives including past performance ($NBI & $XBI tripled following past downturns). Sentiment can turn quickly. Bruce Booth’s review & #Biotech Hangout quoted. Tim Opler: “People haven’t gotten the memo yet” Update. Report now live: https://lnkd.in/ePpJZP6p